SCHEMBL7958713

SCHEMBL7958713

c1ccc(CC2CCN(Cc3cccc(-c4ccccc4)n3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 2/20 0.60
KDM4E B2RXH2 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
LMNA P02545 1/20 0.56
MAPK1 P28482 1/20 0.56
ALDH1A1 P00352 3/20 0.53
ATM Q13315 4/20 0.53
GLA P06280 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
GRIN1 Q05586 1/20 0.51
GRIN2B Q13224 1/20 0.51
PRMT3 O60678 1/20 0.49
CARM1 Q86X55 1/20 0.49
PRMT6 Q96LA8 1/20 0.49
PRMT1 Q99873 1/20 0.49
PRMT8 Q9NR22 1/20 0.49
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10372034 0.81 HSD11B1 (0.54) KDM4EALDH1A1GRIN2BCARM1PRMT6
SCHEMBL7974993 0.80 LMNA (0.60) CCR3KDM4ESMN1; SMN2LMNAMAPK1
SCHEMBL29501461 0.79 KDM4E (0.57) KDM4EALDH1A1ATMGRIN2BMEN1
Hydrochloric Acid SCHEMBL7968770 0.79 LMNA (0.59) CCR3KDM4ESMN1; SMN2LMNAMAPK1
SCHEMBL2958775 0.77 KDM4E (0.47) CCR3KDM4ESMN1; SMN2ALDH1A1ATM
SCHEMBL2004615 0.76 CCR3 (1.00) CCR3KDM4EALDH1A1ATMGLA
SCHEMBL10374099 0.76 HTR2A (0.51) CCR3LMNAL3MBTL1MEN1KMT2A
SCHEMBL10372369 0.76 MEN1 (0.58) MAPTMEN1KMT2A
SCHEMBL10373204 0.76 HSD11B1 (0.46) SMN1; SMN2LMNAMAPTHTTL3MBTL1
SCHEMBL7977320 0.75 CCR3 (0.96) CCR3KDM4EALDH1A1ATMGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281359-B1 PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2001-08-28 US disclosed
US-6221871-B1 TREATING SCHIZOPHRENIA, DEPRESSION OR PARKINSON'S DISEASE NEUROGEN CORPORATION 2001-04-24 US disclosed
US-5594141-A ANTIPSYCHOTIC AND ANTIDEPRESSANT AGENTS; PARKINSON'S DISEASE NEUROGEN CORPORATION (US) 1997-01-14 US disclosed